Rapid and sustained improvement of dupilumab‐associated head and neck erythema with topical brimonidine
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15471
Abstract: Dear Editor, Recalcitrant head and neck erythema (RHNE) is an adverse effect that has been observed in patients treated with dupilumab with a frequency that varies from 3% to 10%. However, currently its management remains… read more here.
Keywords: improvement; head neck; brimonidine; plus hydrocortisone ... See more keywords